Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 207

The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.

High throughput toxicity screening and intracellular detection of nanomaterials

Open access
Collins, Andrew R., Annangi, Balasubramanyam, Rubio, Laura, Marcos, Ricard, Dorn, Marco, Merker, Carolin, Estrela‐Lopis, Irina, Cimpan, Mihaela Roxana, Ibrahim, Mohamed, Cimpan, Emil, Ostermann, Melanie, Sauter, Alexander, Yamani, Naouale El, Shaposhnikov, Sergey, Chevillard, Sylvie, Paget, Vincent, Grall, Romain, Delic, Jozo, de‐Cerio, Felipe Goñi‐, Suarez‐Merino, Blanca, Fessard, Valérie, Hogeveen, Kevin N., Fjellsbø, Lise Maria, Pran, Elise Runden, Brzicova, Tana, Topinka, Jan, Silva, Maria João, Leite, P. E., Ribeiro, A. R., Granjeiro, J. M., Grafström, Roland, Prina‐Mello, Adriele, Dusinska, Maria·2017·WIREs Nanomedicine and Nanobiotechnology

Abstract

With the growing numbers of nanomaterials (NMs), there is a great demand for rapid and reliable ways of testing NM safety—preferably using in vitro approaches, to avoid the ethical dilemmas associated with animal research. Data are needed for developing intelligent testing strategies for risk assessment of NMs, based on grouping and read‐across approaches. The adoption of high throughput screening (HTS) and high content analysis (HCA) for NM toxicity testing allows the testing of numerous materials at different concentrations and on different types of cells, reduces the effect of inter‐experimental variation, and makes substantial savings in time and cost.HTS/HCA approaches facilitate the classification of key biological indicators of NM‐cell interactions. Validation of in vitroHTS tests is required, taking account of relevance to in vivo results.HTS/HCA approaches are needed to assess dose‐ and time‐dependent toxicity, allowing prediction of in vivo adverse effects. Several HTS/HCA methods are being validated and applied for NM testing in the FP7 project NANoREG, including Label‐free cellular screening of NM uptake, HCA, High throughput flow cytometry, Impedance‐based monitoring, Multiplex analysis of secreted products, and genotoxicity methods—namely High throughput comet assay, High throughput in vitro micronucleus assay, and γH2AX assay. There are several technical challenges with HTS/HCA for NM testing, as toxicity screening needs to be coupled with characterization of NMs in exposure medium prior to the test; possible interference of NMs with HTS/HCA techniques is another concern. Advantages and challenges of HTS/HCA approaches in NM safety are discussed.WIREs Nanomed Nanobiotechnol 2017, 9:e1413. doi: 10.1002/wnan.1413 This article is categorized under:Therapeutic Approaches and Drug Discovery > Emerging Technologies Toxicology and Regulatory Issues in Nanomedicine > Regulatory and Policy Issues in Nanomedicine Toxicology and Regulatory Issues in Nanomedicine > Toxicology of Nanomaterials

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/wnan.1413

Cites

7 of 7 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 7 references

Cited by

See all 207

Metadata

Authors
Collins, A. R., Annangi, B., Rubio, L., Marcos, R., Dorn, M., Merker, C., Estrela‐Lopis, I., Cimpan, M. R., Ibrahim, M., Cimpan, E., Ostermann, M., Sauter, A., Yamani, N. E., Shaposhnikov, S., Chevillard, S., Paget, V., Grall, R., Delic, J., de‐Cerio, F. G., Suarez‐Merino, B., Fessard, V., Hogeveen, K. N., Fjellsbø, L. M., Pran, E. R., Brzicova, T., Topinka, J., Silva, M. J., Leite, P. E., Ribeiro, A. R., Granjeiro, J. M., Grafström, R., Prina‐Mello, A., & Dusinska, M.
Venue
WIREs Nanomedicine and Nanobiotechnology
Publisher
Wiley
Published
2016-06-07
Volume
9
Issue
1
ISSN
  • 1939-0041 (ISSN-L)
  • 1939-5116
OpenAlex
W2416172908
Cited by
207
References
7
FWCI
12.52
Type
journal article
Language
en
Open access
hybrid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: High throughput toxicity screening and intracellular detection of nanomaterials. https://app.cochat.ai/papers/10.1002/wnan.1413
The paper
Collins, A. R., Annangi, B., Rubio, L., Marcos, R., Dorn, M., Merker, C., Estrela‐Lopis, I., Cimpan, M. R., Ibrahim, M., Cimpan, E., Ostermann, M., Sauter, A., Yamani, N. E., Shaposhnikov, S., Chevillard, S., Paget, V., Grall, R., Delic, J., de‐Cerio, F. G., . . . Dusinska, M. (2017). High throughput toxicity screening and intracellular detection of nanomaterials. WIREs Nanomedicine and Nanobiotechnology. https://doi.org/10.1002/wnan.1413

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.